Promethera Biosciences Competitors and Similar CompaniesClear all

Intercept Pharmaceuticals's competitors and similar companies include Novartis and Genfit.

	Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.	Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
Founding Date	Founding Date 2002	Founding Date 1996	Founding Date 1999
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech drug development medical diagnostics pharma
Locations	Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more	Locations Loos, FR HQ Cambridge, US
Employees	Employees 58321% increase	Employees 75,883	Employees 180
Valuation ($)	Valuation ($) 794.7 m	Valuation ($) N/A	Valuation ($) 280.8 m
Financial
Revenue (est.)	Revenue (est.) $285.7m (FY, 2022)	Revenue (est.) $56.7b (FY, 2025)	Revenue (est.) €65.4m (FY, 2025)
Cost of goods	Cost of goods $984k (FY, 2022)	Cost of goods $8.4b (FY, 2025)	Cost of goods €302k (FY, 2025)
Gross profit	Gross profit $284.7m (FY, 2022)	Gross profit $49.8b (FY, 2025)	Gross profit €70.8m (FY, 2025)
Net income	Net income $221.8m (FY, 2022)	Net income $14b (FY, 2025)	Net income (€86m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 55m	Total funding raised $ 6.5m	Total funding raised N/A